Guest Episode

How metabolic and immune system dysfunction drive the aging process, the role of NAD, promising interventions, aging clocks, and more

Ep. #359 with Eric Verdin, M.D.

Guest Episode

A new era of longevity science: models of aging, human trials of rapamycin, biological clocks, promising compounds, and lifestyle interventions

Ep. #357 with Brian Kennedy, Ph.D.

Podcast Episode

Aging well: Peter shares strategies for improving longevity with residents at a senior living center

Ep. #342

Guest Episode

Longevity roundtable — the science of aging, geroprotective molecules, lifestyle interventions, challenges in research, and more

Ep. #333 with Steven Austad, Ph.D., Matt Kaeberlein, Ph.D., Richard Miller, M.D., Ph.D.

Podcast Episode

Longevity 101

Ep. #311

The difference between a 'clean' drug and a 'dirty' drug

Guest Episode

Are there “biomarkers” for aging?

with Matt Kaeberlein, Ph.D.

AMA

"Anti-Aging" Drugs — NAD+, metformin, & rapamycin

Ep. #207 (AMA #35) with Matt Kaeberlein, Ph.D.

Guest Episode

The challenges of defining aging

with Matt Kaeberlein, Ph.D.

Guest Episode

Potential Risks of NAD Supplements

with Iñigo San-Millán, Ph.D.

Guest Episode

About TAME: A Metformin Anti-Aging Clinical Trial

with Nir Barzilai, M.D.

Podcast Episode

Exercising for longevity: strength, stability, zone 2, zone 5, and more

Ep. #206

Peter on the four horsemen of chronic disease

The importance of preserving strength and muscle mass as we age

AMA

What lab tests can (and cannot) inform us about our overall objective of longevity

Ep. #111 (AMA #14)